23 mai
12:00 |

The Impact of Demographic Changes on Blood Donation and Transfusion Demand, Implications of a Population Based Longitudinal Study

Special guest speaker Dr. Andreas Greinacher University Hospital Greifswald, Germany Head of the Institute of Immunology and Transfusion Medicine Objectives 1. To understand the association between demographic changes and blood donation numbers To become aware that the baby boom generation who is

22 oct
8:00 | St. John's, Newfoundland and Labrador

CANNT conference 2026

Cette conférence se déroulera exclusivement en anglais. CANNT conference 2026 The Canadian Association of Nephrology Nurses and Technologists (CANNT) Conference will be hosted in the heart of St. John's, Newfoundland and Labrador. Date: October 22-24, 2026 Location: Delta Hotels St. John's

17 nov
8:00 | Vancouver

20th Annual Earl W. Davie Symposium

This annual 1-day symposium, in honour of Dr. Earl W. Davie, features presentations by leading experts in vascular biology, hemostasis-thrombosis, and cardiovascular and neurologic disease. Dr. Earl Davie’s research had elucidated many areas of coagulation and led to effective treatments for

16 juin
17:30 | Virtual

The FARES-II trial: Is it time to replace FP with PCC as first-line therapy for coagulopathic bleeding in cardiac surgery? - Cloned

Join the next Breakthroughs in blood: Advancements into action webinar as Dr. Keyvan Karkouti discusses Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery: The FARES-II Multicenter Randomized Clinical Trial published in JAMA in March 2025. The webinar will

9 juin
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

19 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

12 mai
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

28 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

14 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des

7 avr
12:00 | Toronto/Virtual

Topic: Sickle Cell Disease and Transfusion Medicine - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned - Cloned

Presented by Dr. Hayley Merkeley MD FRCPC Medical Director, Adult Red Cell Disorders Program Learning objectives TBA Remarque : la séance constitue une activité d’apprentissage de groupe auto-approuvée (Section 1) telle que définie par le programme de maintien du certificat du Collège royal des